{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:26:51Z","timestamp":1791044811555,"version":"4.1.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi240293-4\"><jats:title>Importance<\/jats:title><jats:p>Pathogenic or likely pathogenic (P\/LP) germline <jats:italic>CDH1<\/jats:italic> variants are associated with risk for diffuse gastric cancer and lobular breast cancer (LBC) in the so-called hereditary diffuse gastric cancer (HDGC) syndrome. However, in some circumstances, LBC can be the first manifestation of this syndrome in the absence of diffuse gastric cancer manifestation.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240293-5\"><jats:title>Objectives<\/jats:title><jats:p>To evaluate the frequency of germline <jats:italic>CDH1<\/jats:italic> variants in women with the hereditary LBC (HLBC) phenotype, somatic <jats:italic>CDH1<\/jats:italic> gene inactivation in germline <jats:italic>CDH1<\/jats:italic> variant carriers\u2019 tumor samples, and the association of genetic profiles with clinical-pathological data and survival.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240293-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This single-center, longitudinal, prospective cohort study was conducted from January 1, 1997, to December 31, 2021, with follow-up until January 31, 2023. Women with LBC seen at the European Institute of Oncology were included. Testing for germline <jats:italic>CDH1<\/jats:italic>, <jats:italic>BRCA1<\/jats:italic>, and <jats:italic>BRCA2<\/jats:italic> genes was performed. Somatic profiling was assessed for germline <jats:italic>CDH1<\/jats:italic> carriers.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240293-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Accurate estimates of prevalence of germline <jats:italic>CDH1<\/jats:italic> variants among patients with HLBC and the association of somatic sequence alteration with HLBC syndrome. The Kaplan-Meier method and a multivariable Cox proportional hazards regression model were applied for overall and disease-free survival analysis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240293-8\"><jats:title>Results<\/jats:title><jats:p>Of 5429 cases of primary LBC, familial LBC phenotype accounted for 1867 (34.4%). A total of 394 women with LBC were tested, among whom 15 germline <jats:italic>CDH1<\/jats:italic> variants in 15 unrelated families were identified. Among these variants, 6 (40.0%) were P\/LP, with an overall frequency of 1.5% (6 of 394). Of the 6 probands with P\/LP <jats:italic>CDH1<\/jats:italic> LBC, 5 (83.3%) had a positive family history of BC and only 1 (16.7%) had sporadic juvenile early-onset LBC. No germline <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> variants were identified in <jats:italic>CDH1<\/jats:italic> carriers. An inactivating <jats:italic>CDH1<\/jats:italic> mechanism (second hit) was identified in 4 of 6 explored matched tumor samples (66.7%) in P\/LP germline carriers. The P\/LP <jats:italic>CDH1<\/jats:italic> LBC variant carriers had a significantly lower age at diagnosis compared with the group carrying <jats:italic>CDH1<\/jats:italic> variants of unknown significance or likely benign (42.5 [IQR, 38.3-43.0] vs 51.0 [IQR, 45.0-53.0] years; <jats:italic>P<\/jats:italic>\u2009=\u2009.03).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240293-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cohort study, P\/LP germline <jats:italic>CDH1<\/jats:italic> variants were identified in individuals not fulfilling the classic clinical criteria for HDGC screening, suggesting that identification of these variants may provide a novel method to test women with LBC with early age at diagnosis and\/or positive family history of BC.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.7862","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T15:01:26Z","timestamp":1713884486000},"page":"e247862","source":"Crossref","is-referenced-by-count":17,"title":["<i>CDH1<\/i> Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype"],"prefix":"10.1001","volume":"7","author":[{"given":"Giovanni","family":"Corso","sequence":"first","affiliation":[{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy"},{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Marino","sequence":"additional","affiliation":[{"name":"Clinic Unit of Oncogenomics, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Zanzottera","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Genetics, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Bernard","sequence":"additional","affiliation":[{"name":"Clinic Unit of Oncogenomics, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Macis","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Genetics, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Figueiredo","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Pereira","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Massari","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Barberis","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Margherita","family":"De Scalzi","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Vincenzo","family":"Taormina","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Sajjadi","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sangalli","sequence":"additional","affiliation":[{"name":"Data Management, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"D\u2019Ecclesiis","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Maria","family":"Trovato","sequence":"additional","affiliation":[{"name":"Division of Endoscopy, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rotili","sequence":"additional","affiliation":[{"name":"Division of Breast Imaging, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pesapane","sequence":"additional","affiliation":[{"name":"Division of Breast Imaging, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[{"name":"Division of Breast Imaging, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology \u201cG.A. Maccacaro,\u201d University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Galimberti","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Guerini-Rocco","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Genetics, IEO, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy"},{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"issue":"7","key":"zoi240293r1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jmedgenet-2018-105337","article-title":"Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.","volume":"55","author":"Corso","year":"2018","journal-title":"J Med Genet"},{"issue":"12","key":"zoi240293r2","first-page":"873","article-title":"Familial gastric cancer: overview and guidelines for management.","volume":"36","author":"Caldas","year":"1999","journal-title":"J Med Genet"},{"issue":"7","key":"zoi240293r3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/jmedgenet-2012-101472","article-title":"CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.","volume":"50","author":"Benusiglio","year":"2013","journal-title":"J Med Genet"},{"issue":"4","key":"zoi240293r4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/bjc.2013.792","article-title":"Germline CDH1 mutations in bilateral lobular carcinoma in situ.","volume":"110","author":"Petridis","year":"2014","journal-title":"Br J Cancer"},{"issue":"7","key":"zoi240293r5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/jmg.2009.074237","article-title":"Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.","volume":"47","author":"Fitzgerald","year":"2010","journal-title":"J Med Genet"},{"issue":"6","key":"zoi240293r6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.","volume":"52","author":"van der Post","year":"2015","journal-title":"J Med Genet"},{"issue":"8","key":"zoi240293r7","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","article-title":"Hereditary diffuse gastric cancer: updated clinical practice guidelines.","volume":"21","author":"Blair","year":"2020","journal-title":"Lancet Oncol"},{"issue":"35","key":"zoi240293r8","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1200\/JCO.21.00640","article-title":"Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast.","volume":"39","author":"Yadav","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi240293r9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/CEJ.0000000000000688","article-title":"CDH1 germline mutations in families with hereditary lobular breast cancer.","volume":"31","author":"Girardi","year":"2022","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"zoi240293r10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.v29:11","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.","volume":"29","author":"Plon","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"zoi240293r13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/jmg-2022-108807","article-title":"Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines.","volume":"60","author":"Luo","year":"2023","journal-title":"J Med Genet"},{"issue":"5","key":"zoi240293r15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"zoi240293r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033783","article-title":"E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.","volume":"7","author":"Sim\u00f5es-Correia","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"zoi240293r17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"issue":"12","key":"zoi240293r18","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/bioinformatics\/btr254","article-title":"A graphical interface for the FoldX forcefield.","volume":"27","author":"Van Durme","year":"2011","journal-title":"Bioinformatics"},{"issue":"7","key":"zoi240293r19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1200\/JCO.2012.44.4612","article-title":"Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.","volume":"31","author":"Corso","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi240293r20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1470-2045(22)00643-X","article-title":"Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.","volume":"24","author":"Garcia-Pelaez","year":"2023","journal-title":"Lancet Oncol"},{"issue":"6","key":"zoi240293r21","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/cancers13061269","article-title":"Geographical distribution of E-cadherin germline mutations in the context of diffuse gastric cancer: a systematic review.","volume":"13","author":"Corso","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"zoi240293r22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/jamasurg.2021.5118","article-title":"Association between hereditary lobular breast cancer due to CDH1 variants and gastric cancer risk.","volume":"157","author":"Gamble","year":"2022","journal-title":"JAMA Surg"},{"issue":"1","key":"zoi240293r23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00404-017-4551-1","article-title":"CDH1 mutation screen in a BRCA1\/2-negative familial breast-\/ovarian cancer cohort.","volume":"297","author":"Stuebs","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"zoi240293r24","first-page":"1696","article-title":"Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis.","volume":"53","author":"Oka","year":"1993","journal-title":"Cancer Res"},{"issue":"4","key":"zoi240293r25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01092751","article-title":"Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas.","volume":"430","author":"Hunt","year":"1997","journal-title":"Virchows Arch"},{"issue":"4","key":"zoi240293r26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9","article-title":"Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.","volume":"183","author":"De Leeuw","year":"1997","journal-title":"J Pathol"},{"issue":"24","key":"zoi240293r27","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","article-title":"E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers.","volume":"14","author":"Berx","year":"1995","journal-title":"EMBO J"},{"issue":"7","key":"zoi240293r28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bjc.6690815","article-title":"Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.","volume":"81","author":"Huiping","year":"1999","journal-title":"Br J Cancer"},{"issue":"3","key":"zoi240293r29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.","volume":"92","author":"Droufakou","year":"2001","journal-title":"Int J Cancer"},{"issue":"7","key":"zoi240293r30","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","article-title":"Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.","volume":"136","author":"Oliveira","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"zoi240293r31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond.","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"issue":"9","key":"zoi240293r32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2019.1208","article-title":"Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers.","volume":"5","author":"Roberts","year":"2019","journal-title":"JAMA Oncol"},{"issue":"12","key":"zoi240293r33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/jmedgenet-2019-105991","article-title":"Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria.","volume":"56","author":"Xicola","year":"2019","journal-title":"J Med Genet"},{"issue":"1","key":"zoi240293r34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(22)00700-8","article-title":"Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.","volume":"24","author":"Lee","year":"2023","journal-title":"Lancet Oncol"},{"key":"zoi240293r11","unstructured":"National Center for Biotechnology Information, National Institutes of Health. ClinVar. Accessed October 24, 2023. https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/"},{"key":"zoi240293r12","unstructured":"Leiden Open Variation Database. Home page. Accessed October 24, 2023. https:\/\/www.lovd.nl\/"},{"key":"zoi240293r14","unstructured":"BRCA Exchange. Home page. Accessed October 24, 2023. https:\/\/brcaexchange.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2817867\/corso_2024_oi_240293_1713196841.54583.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T15:01:40Z","timestamp":1713884500000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2817867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.7862","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}